Tessera

Tessera Therapeutics is a company that is leading the way in a new kind of medical technology called Gene Writing. This technology is designed to treat diseases by making changes directly to a person's genetic code. The goal is to cure diseases by writing helpful messages into the genome, which is like the instruction manual for the body. Tessera's approach is different from other genetic treatments because it can make both small and large changes to the genome, and these changes are permanent. This means that the treatment could potentially cure diseases rather than just manage symptoms. Tessera is also working on ways to deliver these genetic changes precisely where they are needed in the body, using a method that does not involve viruses. This makes the treatment safer and more targeted. The company's work is focused on addressing major medical needs that are not currently being met, with the aim of providing curative and accessible therapies. Tessera has been making significant progress in this field, as highlighted in their recent press releases.